Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Xencor Inks Second Deal With Janssen Pharmaceuticals This Year | Los Angeles Business Journal,

Later this year or early next year, Xencor is slated to begin a Phase 2 clinical trial of this drug combination in lymphoma patients. Work on this trial is …, Later this year or early next year, Xencor is slated to begin a Phase 2 clinical trial of this drug combination in lymphoma patients. Work on this trial is …, Read More

Scroll to Top